119 related articles for article (PubMed ID: 27336755)
1. Prognostic Value of Baseline 18F-FDG PET/CT Functional Parameters in Patients with Advanced Lung Adenocarcinoma Stratified by EGFR Mutation Status.
Wang D; Zhang M; Gao X; Yu L
PLoS One; 2016; 11(6):e0158307. PubMed ID: 27336755
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of integrating total metabolic tumor volume and EGFR mutation status in patients with lung adenocarcinoma.
Jiang M; Guo X; Chen P; Zhang X; Gao Q; Zhang J; Zheng J
PeerJ; 2024; 12():e16807. PubMed ID: 38250731
[TBL] [Abstract][Full Text] [Related]
3. The value of dynamic FDG PET/CT in the differential diagnosis of lung cancer and predicting EGFR mutations.
Wumener X; Zhang Y; Zang Z; Du F; Ye X; Zhang M; Liu M; Zhao J; Sun T; Liang Y
BMC Pulm Med; 2024 May; 24(1):227. PubMed ID: 38730287
[TBL] [Abstract][Full Text] [Related]
4. Value of
Lv Z; Fan J; Xu J; Wu F; Huang Q; Guo M; Liao T; Liu S; Lan X; Liao S; Geng W; Jin Y
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):735-750. PubMed ID: 29164298
[TBL] [Abstract][Full Text] [Related]
5. Effect of Epidermal Growth Factor Receptor Mutation on Positron Emission Tomography/Computed Tomography in Lung Cancer.
Park JS; Park HY; Choi Y
Anticancer Res; 2024 Jun; 44(6):2681-2687. PubMed ID: 38821597
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of
Zhang Q; Tao X; Yuan P; Zhang Z; Ying J; Guo L; Li N; Wang S; Li J; Liu Y; Guo W; Zhao S; Wu N
Cancer Med; 2023 Nov; 12(22):20864-20877. PubMed ID: 37965789
[TBL] [Abstract][Full Text] [Related]
7. Dynamic prognostication using conditional survival analysis for patients with operable lung adenocarcinoma.
Kim W; Lee HY; Jung SH; Woo MA; Kim HK; Choi YS; Kim J; Zo JI; Shim YM; Han J; Jeong JY; Choi JY; Lee KS
Oncotarget; 2017 May; 8(19):32201-32211. PubMed ID: 27793026
[TBL] [Abstract][Full Text] [Related]
8. Exploring the correlation between HER2 alterations and
Ruan M; Chang C; Sun J; Liu L; Wang L; Lei B; Yan H; Zhang H; Xie W; Wang Y
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14493-14507. PubMed ID: 37572120
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of serum CYFRA 21-1 in patients with advanced lung adenocarcinoma: a retrospective study.
Ono A; Takahashi T; Mori K; Akamatsu H; Shukuya T; Taira T; Kenmotsu H; Naito T; Murakami H; Nakajima T; Endo M; Yamamoto N
BMC Cancer; 2013 Jul; 13():354. PubMed ID: 23879483
[TBL] [Abstract][Full Text] [Related]
10. SFXN1 as a potential diagnostic and prognostic biomarker of LUAD is associated with
Zhang YH; Liu XS; Gao Y; Yuan LL; Huang ZM; Zhang Y; Liu ZY; Yang Y; Liu XY; Ke CB; Pei ZJ
Lung Cancer; 2024 Feb; 188():107449. PubMed ID: 38184958
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of nomograms for predicting survival probability of patients with advanced adenocarcinoma in different EGFR mutation status.
Chen HC; Tan EC; Liao CH; Lin ZZ; Yang MC
PLoS One; 2019; 14(8):e0220730. PubMed ID: 31419239
[TBL] [Abstract][Full Text] [Related]
12. Differential Prognostic Value of Vascular Invasion in Resected Lung Adenocarcinomas According to Epidermal Growth Factor Receptor Mutational Status.
Lee KH; Chung JH; Cho S; Lee JS; Kim H
Clin Lung Cancer; 2023 Nov; 24(7):e291-e299.e1. PubMed ID: 37479587
[TBL] [Abstract][Full Text] [Related]
13. The application of different machine learning models based on PET/CT images and EGFR in predicting brain metastasis of adenocarcinoma of the lung.
Kong C; Yin X; Zou J; Ma C; Liu K
BMC Cancer; 2024 Apr; 24(1):454. PubMed ID: 38605303
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Values of Primary Tumor Textural Heterogeneity and Blood Biomarkers in High-risk Neuroblastoma.
Vural O; Aydos U; Okur A; Pinarli FG; Atay LÖ
J Pediatr Hematol Oncol; 2023 Oct; 45(7):383-391. PubMed ID: 37027243
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of combining clinical factors,
Lue KH; Chen YH; Chu SC; Lin CB; Wang TF; Liu SH
Ann Nucl Med; 2024 May; ():. PubMed ID: 38704786
[TBL] [Abstract][Full Text] [Related]
16. Transfer learning-based PET/CT three-dimensional convolutional neural network fusion of image and clinical information for prediction of EGFR mutation in lung adenocarcinoma.
Shao X; Ge X; Gao J; Niu R; Shi Y; Shao X; Jiang Z; Li R; Wang Y
BMC Med Imaging; 2024 Mar; 24(1):54. PubMed ID: 38438844
[TBL] [Abstract][Full Text] [Related]
17. Density of tumor-infiltrating NK and Treg cells is associated with 5 years progression-free and overall survival in resected lung adenocarcinoma.
Szentkereszty M; Ladányi A; Gálffy G; Tóvári J; Losonczy G
Lung Cancer; 2024 Jun; 192():107824. PubMed ID: 38761665
[TBL] [Abstract][Full Text] [Related]
18. Subregion-specific
Wang Y; Yang G; Gao X; Li L; Zhu H; Yi H
Am J Nucl Med Mol Imaging; 2024; 14(2):134-143. PubMed ID: 38737644
[TBL] [Abstract][Full Text] [Related]
19. Clinico-pathological characteristics of IGFR1 and VEGF-A co-expression in early and locally advanced-stage lung adenocarcinoma.
Liu W; Xia J; Du Q; Wang J; Mei T; Qin T
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16365-16376. PubMed ID: 37702808
[TBL] [Abstract][Full Text] [Related]
20. Association between cigarette smoking history, metabolic phenotypes, and
Zhang X; Guo X; Gao Q; Zhang J; Zheng J; Zhao G; Okuda K; Tartarone A; Jiang M
J Thorac Dis; 2023 Oct; 15(10):5689-5699. PubMed ID: 37969305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
